Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Reiss

Showing results (191-200 of 509) with videos related to

Pageof 51
Sort By:
AIDS (London, England)|June 18, 2009
Continuous antiretroviral therapy decreases bone mineral densityBirgit Grund, Grace Peng, Cynthia L Gibert, et al.
Journal of Hepatology|April 16, 2013
Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?Jürgen K Rockstroh, Lars Peters, Daniel Grint, et al.
AIDS (London, England)|January 9, 2010
The effects of intermittent, CD4-guided antiretroviral therapy on body composition and metabolic parametersEsteban Martinez, Fehmida Visnegarwala, Birgit Grund, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 5, 2002
Viral replication under combination antiretroviral therapy: a comparison of four different regimensAzra C Ghani, Neil M Ferguson, Christophe Fraser, et al.
The Journal of Infectious Diseases|June 1, 2007
Effects of nevirapine, compared with lamivudine, on lipids and lipoproteins in HIV-1-uninfected newborns: the stopping infection from mother-to-child via breast-feeding in Africa lipid substudyRaaj R Sankatsing, Ferdinand W Wit, Nadine Pakker, et al.
The Lancet. HIV|February 12, 2023
Long-term evolution of comorbidities and their disease burden in individuals with and without HIV as they age: analysis of the prospective AGE<sub>h</sub>IV cohort studyEveline Verheij, Anders Boyd, Ferdinand W Wit, et al.
The Journal of Infectious Diseases|February 19, 2021
The Complement Pathway Is Activated in People With Human Immunodeficiency Virus and Is Associated With Non-AIDS ComorbiditiesIvan Vujkovic-Cvijin, Ornella Sortino, Eveline Verheij, et al.
Antiviral Therapy|September 28, 2012
The clinical benefits of antiretroviral therapy in severely immunocompromised HIV-1-infected patients with and without complete viral suppressionAmanda Mocroft, Wendy P Bannister, Ole Kirk, et al.
Journal of the American Chemical Society|October 11, 2017
Growth Mechanism and Surface State of CuInS<sub>2</sub> Nanocrystals Synthesized with DodecanethiolMarina Gromova, Aurélie Lefrançois, Louis Vaure, et al.
Atherosclerosis|July 5, 2008
Increased carotid intima-media thickness in HIV patients treated with protease inhibitors as compared to non-nucleoside reverse transcriptase inhibitorsRaaj R Sankatsing, Ferdinand W Wit, Martin Vogel, et al.
Pageof 51

Showing results (191-200 of 509) with videos related to

Sort By:
Pageof 51
AIDS (London, England)|June 18, 2009
Continuous antiretroviral therapy decreases bone mineral densityBirgit Grund, Grace Peng, Cynthia L Gibert, et al.
Journal of Hepatology|April 16, 2013
Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?Jürgen K Rockstroh, Lars Peters, Daniel Grint, et al.
AIDS (London, England)|January 9, 2010
The effects of intermittent, CD4-guided antiretroviral therapy on body composition and metabolic parametersEsteban Martinez, Fehmida Visnegarwala, Birgit Grund, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 5, 2002
Viral replication under combination antiretroviral therapy: a comparison of four different regimensAzra C Ghani, Neil M Ferguson, Christophe Fraser, et al.
The Journal of Infectious Diseases|June 1, 2007
Effects of nevirapine, compared with lamivudine, on lipids and lipoproteins in HIV-1-uninfected newborns: the stopping infection from mother-to-child via breast-feeding in Africa lipid substudyRaaj R Sankatsing, Ferdinand W Wit, Nadine Pakker, et al.
The Lancet. HIV|February 12, 2023
Long-term evolution of comorbidities and their disease burden in individuals with and without HIV as they age: analysis of the prospective AGE<sub>h</sub>IV cohort studyEveline Verheij, Anders Boyd, Ferdinand W Wit, et al.
The Journal of Infectious Diseases|February 19, 2021
The Complement Pathway Is Activated in People With Human Immunodeficiency Virus and Is Associated With Non-AIDS ComorbiditiesIvan Vujkovic-Cvijin, Ornella Sortino, Eveline Verheij, et al.
Antiviral Therapy|September 28, 2012
The clinical benefits of antiretroviral therapy in severely immunocompromised HIV-1-infected patients with and without complete viral suppressionAmanda Mocroft, Wendy P Bannister, Ole Kirk, et al.
Journal of the American Chemical Society|October 11, 2017
Growth Mechanism and Surface State of CuInS<sub>2</sub> Nanocrystals Synthesized with DodecanethiolMarina Gromova, Aurélie Lefrançois, Louis Vaure, et al.
Atherosclerosis|July 5, 2008
Increased carotid intima-media thickness in HIV patients treated with protease inhibitors as compared to non-nucleoside reverse transcriptase inhibitorsRaaj R Sankatsing, Ferdinand W Wit, Martin Vogel, et al.
Pageof 51